USANA Health Sciences, Inc.
USNA
$30.02
$0.521.76%
NYSE
| 03/29/2025 | 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.54% | -3.38% | -6.16% | -10.64% | -8.28% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.54% | -3.38% | -6.16% | -10.64% | -8.28% |
| Cost of Revenue | 21.77% | -8.90% | -7.69% | -6.91% | -11.23% |
| Gross Profit | 6.69% | -2.07% | -5.78% | -11.46% | -7.56% |
| SG&A Expenses | 13.35% | 7.96% | -5.13% | -9.26% | -7.48% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.13% | 4.34% | -5.69% | -8.78% | -8.30% |
| Operating Income | -36.49% | -66.10% | -11.39% | -26.89% | -8.09% |
| Income Before Tax | -38.26% | -60.81% | -9.37% | -24.64% | -4.88% |
| Income Tax Expenses | -29.55% | -39.61% | -12.88% | 2.66% | 4.51% |
| Earnings from Continuing Operations | -43.82% | -73.26% | -6.52% | -39.67% | -10.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -43.15% | -73.43% | -6.52% | -39.67% | -10.04% |
| EBIT | -36.49% | -66.10% | -11.39% | -26.89% | -8.09% |
| EBITDA | -13.73% | -55.00% | -8.18% | -21.60% | -7.67% |
| EPS Basic | -42.77% | -73.23% | -5.70% | -38.88% | -9.52% |
| Normalized Basic EPS | -37.18% | -60.69% | -8.58% | -23.67% | -4.34% |
| EPS Diluted | -43.02% | -73.72% | -5.70% | -39.33% | -9.47% |
| Normalized Diluted EPS | -36.89% | -60.69% | -8.00% | -23.58% | -4.74% |
| Average Basic Shares Outstanding | -0.65% | -0.77% | -0.87% | -1.28% | -0.57% |
| Average Diluted Shares Outstanding | -1.12% | -0.77% | -1.49% | -1.38% | -0.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |